Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Treatment outcomes of Her-2 positive Breast Cancer in the absence of Her-2 targeting agents at Groote Schuur Hospital, Cape Town, South Africa. Are we doing enough?
Purpose: Breast Cancer has an estimated 2.3 billion cases globally. It is the second most common cause of cancer-related mortality in Sub-Saharan Africa. The addition of anti- Her-2 targeted therapy (Trastuzumab) to either adjuvant or neo-adjuvant treatment significantly improves disease-free surviv...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | Eng |
| Published: |
Division of Radiology
2024
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Treatment outcomes of Her-2 positive Breast Cancer in the absence of Her-2 targeting agents at Groote Schuur Hospital, Cape Town, South Africa. Are we doing enough?
- HER2-ADC and HER2-TKI Overcomes HER2 Amplification as an Acquired Resistance to Zongertinib – A Case Report
- Artificial Intelligence-Driven Quantitative HER2 Scoring and Spatial Bystander Effect Modeling for ADC Response Stratification in HER2-Low Breast Cancer
- A retrospective review of CTPA confirmed pulmonary emboli in COVID-19 patients admitted to Groote Schuur Hospital, Cape Town
- Radiosensitisation of low HER-2 expressing human breast cancer cell lines
- Evaluating the yield of brain CT examinations in patients presenting with first onset seizures at the Groote Schuur Hospital, Cape Town
- A review of the Groote Schuur hospital experience of low-velocity non-missile penetrating orbital and transorbital stab wounds